What investment strategy does Ibionext focus on?

Ibionext focuses on VC, Growth, Buyout strategies in the private equity space.

How many portfolio companies does Ibionext have?

Ibionext has 5 active portfolio companies and 1 completed exit and 1 fund tracked on GP Intel.

Where is Ibionext headquartered?

Ibionext is headquartered in Paris, France.

What is Ibionext's assets under management?

Ibionext manages approximately €600M in assets under management.

What sectors does Ibionext invest in?

Ibionext invests across Healthcare, Software, TMT, Industrials.

Home/GPs/Ibionext

Ibionext

Paris, France·Founded 2015·

Venture Capital Growth Equity Buyout

·ibionext.com

iBionext is France's first Venture Studio dedicated to healthcare, specializing in the creation, development, and financing of innovative startups in biotech, medtech, digital health, and deep tech sectors. Founded in 2012 and based in…Read full bio

AUM

€600M

Funds

Portfolio

SectorsHealthcareSoftwareTMTIndustrials

Key facts

HQParis, France

Founded2015

Websiteibionext.com

Recent exits

GrAI Matter Labs

TMT · 2023

Coverage notes

1 fund tracked, 6 portfolio companies (5 active · 1 realized). Verified weekly from public filings and deal announcements.

About Ibionext

iBionext is France's first Venture Studio dedicated to healthcare, with €600 million of assets under management as of December 2024, founded in 2015 and headquartered in Paris. The firm specialises in the creation, development and financing of innovative startups in biotech, MedTech, digital health and deep tech sectors, combining venture capital deployment with active company-building expertise.

Investment thesis

iBionext combines venture studio operations (creating new companies internally) with traditional venture capital investments in external biotech, MedTech, digital health and deep tech startups. Investment stages span early-stage seed and Series A with selective growth-stage follow-on commitments. The venture studio model distinguishes iBionext from pure VC peers, enabling proactive company-building alongside selective external investments where market opportunities align with the platform's healthcare focus.

Recent activity

The platform tracks a single dedicated fund vehicle and 6 active portfolio companies across the venture studio and traditional VC programmes. As a venture studio with selective external investments, iBionext maintains long-duration positions aligned with the multi-year company-building cycles typical of healthcare innovation. Detailed buyer names and multiple data available on Pro at €49/month.